GLP-1
The landmark FLOW trial showed semaglutide reduced hard kidney disease endpoints by 24% — here's what the full…
The science on artificial sweeteners and GLP-1 is more complicated than 'zero calories, zero consequences' — here's what…
Tirzepatide produces dramatic reductions in body fat — especially visceral fat — but the science shows that protein…
Semaglutide is a GLP-1 receptor agonist FDA-approved for weight loss that helped clinical trial participants lose nearly 15%…
A 2025 meta-analysis of 85,373 participants confirms GLP-1 receptor agonists significantly reduce major cardiovascular events and kidney failure…
Semaglutide will produce weight loss without a formal diet plan, but every major clinical trial showing the most…
Semaglutide has a roughly seven-day half-life and clears your system in about five weeks after your last dose…
Lipoprotein(a) is a genetically driven cardiovascular risk factor that standard cholesterol treatments rarely address — and GLP-1 receptor…
A science-backed breakdown of Ozempic weight loss advice for men — covering how semaglutide works, what the research…
The FDA has approved an oral semaglutide pill for obesity — here's what the science actually shows and…